Known and unknown: Exosome secretion in tumor microenvironment needs more exploration

Yang D, Zhang W, Zhang H, et al. Progress, opportunity, and perspective on exosome isolation — efforts for efficient exosome-based theranostics. Theranostics. 2020;10(8):3684–3707.

Zhang H, Lu J, Liu J, Zhang G, Lu A. Advances in the discovery of exosome inhibitors in cancer. J Enzym Inhib Med Chem. 2020;35(1):1322–1330.

Xu R, Rai A, Chen M, Suwakulsiri W, Greening DW, Simpson RJ. Extracellular vesicles in cancer — implications for future improvements in cancer care. Nat Rev Clin Oncol. 2018;15(10):617–638.

Jiao YJ, Jin DD, Jiang F, et al. Characterization and proteomic profiling of pancreatic cancer-derived serum exosomes. J Cell Biochem. 2019;120(1):988–999.

Hedayat M, Ahmadi M, Shoaran M, Rezaie J. Therapeutic application of mesenchymal stem cells derived exosomes in neurodegenerative diseases: a focus on non-coding RNAs cargo, drug delivery potential, perspective. Life Sci. 2023;320:121566.

Qiu Y, Li P, Zhang Z, Wu M. Insights into exosomal non-coding RNAs sorting mechanism and clinical application. Front Oncol. 2021;11:664904.

Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977.

Shaban SA, Rezaie J, Nejati V. Exosomes derived from senescent endothelial cells contain distinct pro-angiogenic miRNAs and proteins. Cardiovasc Toxicol. 2022;22(6):592–601.

Zhang X, Yuan X, Shi H, Wu L, Qian H, Xu W. Exosomes in cancer: small particle, big player. J Hematol Oncol. 2015;8(1):1–13.

Gurung S, Perocheau D, Touramanidou L, Baruteau J. The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun Signal. 2021;19(1):47.

Feghhi M, Rezaie J, Akbari A, et al. Effect of multi-functional polyhydroxylated polyhedral oligomeric silsesquioxane (POSS) nanoparticles on the angiogenesis and exosome biogenesis in human umbilical vein endothelial cells (HUVECs). Mater Des. 2021;197:109227.

Morishita M, Takahashi Y, Nishikawa M, Takakura Y. Pharmacokinetics of exosomes — an important factor for elucidating the biological roles of exosomes and for the development of exosome-based therapeutics. J Pharmaceut Sci. 2017;106(9):2265–2269.

Jadli AS, Ballasy N, Edalat P, Patel VB. Inside(sight) of tiny communicator: exosome biogenesis, secretion, and uptake. Mol Cell Biochem. 2020;467(1):77–94.

Song L, Tang S, Han X, et al. KIBRA controls exosome secretion via inhibiting the proteasomal degradation of Rab27a. Nat Commun. 2019;10(1):1639.

Takahashi A, Okada R, Nagao K, et al. Publisher correction: exosomes maintain cellular homeostasis by excreting harmful DNA from cells. Nat Commun. 2018;9(1):4109.

Villarroya-Beltri C, Baixauli F, Mittelbrunn M, et al. ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins. Nat Commun. 2016;7:13588.

Mahbubfam S, Rezaie J, Nejati V. Crosstalk between exosomes signaling pathway and autophagy flux in senescent human endothelial cells. Tissue Cell. 2022;76:101803.

Mardi N, Salahpour-Anarjan F, Nemati M, Shahsavari Baher N, Rahbarghazi R, Zarebkohan A. Exosomes; multifaceted nanoplatform for targeting brain cancers. Cancer Lett. 2023;557:216077.

Mardi N, Haiaty S, Rahbarghazi R, et al. Exosomal transmission of viruses, a two-edged biological sword. Cell Commun Signal. 2023;21(1):1–29.

Yue B, Yang H, Wang J, et al. Exosome biogenesis, secretion and function of exosomal miRNAs in skeletal muscle myogenesis. Cell Prolif. 2020;53(7):e12857.

Toh WS, Lai RC, Zhang B, Lim SK. MSC exosome works through a protein-based mechanism of action. Biochem Soc Trans. 2018;46(4):843–853.

Xiong H, Huang Z, Yang Z, et al. Recent progress in detection and profiling of cancer cell-derived exosomes. Small. 2021;17(35):2007971.

Meng W, Hao Y, He C, Li L, Zhu G. Exosome-orchestrated hypoxic tumor microenvironment. Mol Cancer. 2019;18(1):1–14.

Yang Z, Zhong W, Yang L, Wen P, Luo Y, Wu C. The emerging role of exosomes in radiotherapy. Cell Commun Signal. 2022;20(1):171.

Wu H, Chen X, Ji J, et al. Progress of exosomes in the diagnosis and treatment of pancreatic cancer. Genet Test Mol Biomarkers. 2019;23(3):215–222.

Almohammai A, Rahbarghazi R, Keyhanmanesh R, Rezaie J, Ahmadi M. Asthmatic condition induced the activity of exosome secretory pathway in rat pulmonary tissues. J Inflamm. 2021;18(1):14.

Zhao X, Wu D, Ma X, Wang J, Hou W, Zhang W. Exosomes as drug carriers for cancer therapy and challenges regarding exosome uptake. Biomed Pharmacother. 2020;128:110237.

Xie X, Wu H, Li M, et al. Progress in the application of exosomes as therapeutic vectors in tumor-targeted therapy. Cytotherapy. 2019;21(5):509–524.

Ahmadi M, Mahmoodi M, Shoaran M, Nazari-Khanamiri F, Rezaie J. Harnessing normal and engineered mesenchymal stem cells derived exosomes for cancer therapy: opportunity and challenges. Int J Mol Sci. 2022;23(22):13974.

Shao J, Zaro J, Shen Y. Advances in exosome-based drug delivery and tumor targeting: from tissue distribution to intracellular fate. Int J Nanomed. 2020;15:9355–9371.

Liu X, Zhang G, Yu T, et al. CL4-modified exosomes deliver lncRNA DARS-AS1 siRNA to suppress triple-negative breast cancer progression and attenuate doxorubicin resistance by inhibiting autophagy. Int J Biol Macromol. 2023;250:126147.

Kim J, Zhu Y, Chen S, et al. Anti-glioma effect of ginseng-derived exosomes-like nanoparticles by active blood-brain-barrier penetration and tumor microenvironment modulation. J Nanobiotechnol. 2023;21(1):253.

Zhu S, Mao J, Zhang X, et al. CAF-derived exosomal lncRNA FAL1 promotes chemoresistance to oxaliplatin by regulating autophagy in colorectal cancer. Dig Liver Dis. 2024;56(2):330–342.

Chen Y, Li Y, Wu Y, et al. Yiwei decoction promotes apoptosis of gastric cancer cells through spleen-derived exosomes. Front Pharmacol. 2023;14:1144955.

Xie QH, Zheng JQ, Ding JY, et al. Exosome-mediated immunosuppression in tumor microenvironments. Cells. 2022;11(12):1946.

Zhang L, Yu D. Exosomes in cancer development, metastasis, and immunity. Biochim Biophys Acta Rev Cancer. 2019;1871(2):455–468.

Thakur A, Parra DC, Motallebnejad P, Brocchi M, Chen HJ. Exosomes: small vesicles with big roles in cancer, vaccine development, and therapeutics. Bioact Mater. 2022;10:281–294.

Zhang J, Ji C, Zhang H, et al. Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy. Sci Adv. 2022;8(2):eabj8207.

Luo Y, Chen Y, Jin H, et al. The suppression of cervical cancer ferroptosis by macrophages: the attenuation of ALOX15 in cancer cells by macrophages-derived exosomes. Acta Pharm Sin B. 2023;13(6):2645–2662.

Zhu X, Shen H, Yin X, et al. Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype. J Exp Clin Cancer Res. 2019;38:81.

Zhang M, Shao W, Yang T, et al. Conscription of immune cells by light-activatable silencing NK-derived exosome (LASNEO) for synergetic tumor eradication. Adv Sci. 2022;9(22):2201135.

Thakur A, Ke X, Chen YW, et al. The mini player with diverse functions: extracellular vesicles in cell biology, disease, and therapeutics. Protein Cell. 2022;13(9):631–654.

Mohammadi M, Zargartalebi H, Salahandish R, Aburashed R, Yong KW, Sanati-Nezhad A. Emerging technologies and commercial products in exosome-based cancer diagnosis and prognosis. Biosens Bioelectron. 2021;183:113176.

Li J, Xie S, Qu F, Tan W. Aptasensors for cancerous exosome detection. Methods Mol Biol. 2022;2504:3–20.

Luo R, Liu M, Yang Q, et al. Emerging diagnostic potential of tumor-derived exosomes. J Cancer. 2021;12(16):5035–5045.

Yang JC, Hu JJ, Li YX, Luo W, Liu JZ, Ye DW. Clinical applications of liquid biopsy in hepatocellular carcinoma. Front Oncol. 2022;12:781820.

Dhani H, Hinestrosa JP, Izaguirre-Carbonell J, Balcer HI, Kurzrock R, Billings PR. Case report: early detection of pancreatic pre-cancer lesion in multimodal approach with exosome liquid biopsy. Front Oncol. 2023;13:1170513.

Lin M, Zhou C, He S, et al. The research advances of exosomes in esophageal cancer. Biomarkers Med. 2019;13(8):685–695.

Sharma S, Salomon C. Techniques associated with exosome isolation for biomarker development: liquid biopsies for ovarian cancer detection. Methods Mol Biol. 2020;2055:181–199.

Thakur A, Xu C, Li WK, et al. In vivo liquid biopsy for glioblastoma malignancy by the AFM and LSPR based sensing of exosomal CD44 and CD133 in a mouse model. Biosens Bioelectron. 2021;191:113476.

Thakur A, Qiu G, Xu C, et al. Label-free sensing of exosomal MCT1 and CD147 for tracking metabolic reprogramming and malignant progression in glioma. Sci Adv. 2020;6(26):eaaz6119.

Li M, Liu T, Cheng W, Jin H, Wang X. A test of miR-128-3p and miR-33a-5p in serum exosome as biomarkers for auxiliary diagnosis of non-small cell lung cancer. J Thorac Dis. 2023;15(5):2616–2626.

Yang P, Zhang Y, Zhang R, et al. Plasma-derived exosomal immunoglobulins IGHV4-4 and IGLV1-40 as new non-small cell lung cancer biomarkers. Am J Cancer Res. 2023;13(5):1923–1937.

Rui T, Wang K, Xiang A, et al. Serum exosome-derived piRNAs could be promising biomarkers for HCC diagnosis. Int J Nanomed. 2023;18:1989–2001.

Moore-Morris T, van Vliet PP, Andelfinger G, Puceat M. Role of epigenetics in cardiac development and congenital diseases. Physiol Rev. 2018;98(4):2453–2475.

Zhang L, Lu Q, Chang C. Epigenetics in health and disease. Adv Exp Med Biol. 2020;1253:3–55.

Guo J, Duan Z, Zhang C, et al. Mouse 4T1 breast cancer cell-derived exosomes induce proinflammatory cytokine production in macrophages via miR-183. J Immunol. 2020;205(10):2916–2925.

Chen J, Zhou Y, Wu M, Yuan Y, Wu W. m6A modification mediates exosomal LINC00657 to trigger breast cancer progression via inducing macrophage M2 polarization. Clin Breast Cancer. 2023;23(5):546–560.

Yao W, Jia X, Zhu L, et al. Exosomal circ_0026611 contributes to lymphangiogenesis by reducing PROX1 acetylation and ubiquitination in human lymphatic endothelial cells (HLECs). Cell Mol Biol Lett. 2023;28(1):13.

Sinha D, Roy S, Saha P, Chatterjee N, Bishayee A. Trends in research on exosomes in cancer progression and anti-cancer therapy. Cancers. 2021;13(2):326.

Rezaie J, Nejati V, Mahmoodi M, Ahmadi M. Mesenchymal stem cells derived extracellular vesicles: a promising nanomedicine for drug delivery system. Biochem Pharmacol. 2022;203:115167.

Ge L, Zhou F, Nie J, Wang X, Zhao Q. Hypoxic colorectal cancer-secreted exosomes deliver miR-210-3p to normoxic tumor cells to elicit a protumoral effect. Exp Biol Med. 2021;246(17):1895–1906.

Guo W, Qiao T, Dong B, Li T, Liu Q, Xu X. The effect of hypoxia-induced exosomes on anti-tumor immunity and its implication for immunotherapy. Front Immunol. 2022;13:915985.

Kumar A, Deep G. Hypoxia in tumor microenvironment regulates exosome biogenesis: molecular mechanisms and translational opportunities. Cancer Lett. 2020;479:23–30.

Panigrahi GK, Praharaj PP, Peak TC, et al. Hypoxia-induced exosome secretion promotes survival of African-American and Caucasian prostate cancer cells. Sci Rep. 2018;8(1):3853.

Wang X, Wu R, Zhai P, et al. Hypoxia promotes EV secretion by impairing lysosomal homeostasis in HNSCC through negative regulation of ATP6V1A by HIF-1α. J Extracell Vesicles. 2023;12(2):e12310.

Jiang TY, Shi YY, Cui XW, et al. PTEN deficiency facilitates exosome secretion and metastasis in cholangiocarcinoma by impairing TFEB-mediated lysosome biogenesis. Gastroenterology. 2023;164(3):424–438.

Jiang H, Zhao H, Zhang M, et al. Hypoxia induced changes of exosome cargo and subsequent biological effects. Front Immunol. 2022;13:824188.

Yu Y, Min Z, Zhou Zhihang, et al. Hypoxia-induced exosomes promote hepatocellular carcinoma proliferation and metastasis via miR-1273f transfer. Exp Cell Res. 2019;385(1):111649.

Shao C, Yang F, Miao S, et al. Role of hypoxia-induced exosomes in tumor biology. Mol Cancer. 2018;17(1):120.

Dorayappan KDP, Wanner R, Wallbillich JJ, et al. Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins. Oncogene. 2018;37(28):3806–3821.

Chi Y, Xin H, Liu Z. Exosomal lncRNA UCA1 derived from pancreatic stellate cells promotes gemcitabine resistance in pancreatic cancer via the SOCS₃/EZH2 axis. Front Oncol. 2021;11:671082.

He G, Peng X, Wei S, et al. Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applications. Mol Cancer. 2022;21(1):19.

Parolini I, Federici C, Raggi C, et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem. 2009;284(49):34211–34222.

Ban JJ, Lee M, Im W, Kim M. Low pH increases the yield of exosome isolation. Biochem Biophys Res Commun. 2015;461(1):76–79.

Wang K, Wei Y, Liu W, et al. Mechanical stress-dependent autophagy component release via extracellular nanovesicles in tumor cells. ACS Nano. 2019;13(4):4589–4602.

Das J, Maji S, Agarwal T, Chakraborty S, Maiti TK. Hemodynamic shear stress induces protective autophagy in HeLa cells through lipid raft-mediated mechanotransduction. Clin Exp Metastasis. 2018;35(3):135–148.

Hassanpour M, Rezaie J, Darabi M, Hiradfar A, Rahbarghazi R, Nouri M. Autophagy modulation altered differentiation capacity of CD146⁺ cells toward endothelial cells, pericytes, and cardiomyocytes. Stem Cell Res Ther. 2020;11(1):139.

Wang L, Xu P, Xie X, et al. Down regulation of SIRT2 reduced ASS induced NSCLC apoptosis through the release of autophagy components via exosomes. Front Cell Dev Biol. 2020;8:601953.

Ji J, Jin D, Xu M, et al. AKR1B1 promotes pancreatic cancer metastasis by regulating lysosome-guided exosome secretion. Nano Res. 2022;15(6):5279–5294.

Li R, Xie Z, Zhang L, et al. The effect of amiloride in decreasing albuminuria in patients with diabetic kidney diseases: a prospective, crossover, open-label study. Ren Fail. 2021;43(1):452–459.

Zhou L, Zhang T, Shao W, et al. Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release. Skeletal Muscle. 2021;11(1):17.

Zhong N, Zhuang W, Huang Q, Wang Q, Jin W. Apatinib inhibits the growth of small cell lung cancer via a mechanism mediated by VEGF, PI3K/Akt and Ki-67/CD31. J Cell Mol Med. 2021;25(21):10039–10048.

Wang Y, Deng M, Chen Q, et al. Apatinib exerts anti-tumor activity to non-Hodgkin lymphoma by inhibition of the Ras pathway. Eur J Pharmacol. 2019;843:145–153.

Yang H, Chen M, Mei Z, Xie C, Zhou Y, Qiu H. Effectiveness and prognostic factors of apatinib treatment in patients with recurrent or advanced cervical carcinoma: a retrospective study. Cancer Med. 2021;10(13):4282–4290.

Li LH, Chen WC, Wu G. Feasibility and tolerance of apatinib plus PD-1 inhibitors for previously treated advanced gastric cancer: a real-world exploratory study. Dis Markers. 2022;2022:4322404.

Nie C, Lv H, Xing Y, et al. The efficacy and safety of apatinib treatment for patients with advanced or recurrent biliary tract cancer: a retrospective study. BMC Cancer. 2021;21(1):189.

Zhao L, Yu Q, Gao C, et al. Studies of the efficacy of low-dose apatinib monotherapy as third-line treatment in patients with metastatic colorectal cancer and apatinib’s novel anti-cancer effect by inhibiting tumor-derived exosome secretion. Cancers. 2022;14(10):2492.

Gu C, Lu H, Qian Z. Matrine reduces the secretion of exosomal circSLC7A6 from cancer-associated fibroblast to inhibit tumorigenesis of colorectal cancer by regulating CXCR5. Biochem Biophys Res Commun. 2020;527(3):638–645.

Fais S. A nonmainstream approach against cancer. J Enzym Inhib Med Chem. 2016;31(6):882–889.

Matboli M, ElGwad AA, Hasanin AH, et al. Pantoprazole attenuates tumorigenesis via inhibition of exosomal secretion in a rat model of hepatic precancerous lesion induced by diethylnitrosamine and 2-acetamidofluorene. J Cell Biochem. 2019;120(9):14946–14959.

Kuo HF, Hsieh CC, Wang SC, et al. Simvastatin attenuates cardiac fibrosis via regulation of cardiomyocyte-derived exosome secretion. J Clin Med. 2019;8(6):794.

Kulshreshtha A, Singh S, Ahmad M, et al. Simvastatin mediates inhibition of exosome synthesis, localization and secretion via multicomponent interventions. Sci Rep. 2019;9(1):16373.

Feng J, Lu H, Ma W, et al. Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer. Protein Cell. 2022;13(11):825–841.

Soraya H, Sani NA, Jabbari N, Rezaie J. Metformin increases exosome biogenesis and secretion in U87 MG human glioblastoma cells: a possible mechanism of therapeutic resistance. Arch Med Res. 2021;52(2):151–162.

Choe EJ, Lee CH, Bae JH, Park JM, Park SS, Baek MC. Atorvastatin enhances the efficacy of immune checkpoint therapy and suppresses the cellular and extracellular vesicle PD-L1. Pharmaceutics. 2022;14(8):1660.

Cocozza F, Menay F, Tsacalian R, et al. Cyclophosphamide enhances the release of tumor exosomes that elicit a specific immune response in vivo in a murine T-cell lymphoma. Vaccine. 2019;37(12):1565–1576.

Fang Y, Zhou W, Rong Y, et al. Exosomal miRNA-106b from cancer-associated fibroblast promotes gemcitabine resistance in pancreatic cancer. Exp Cell Res. 2019;383(1):111543.

Lv LH, Wan YL, Lin Y, et al. Anti-cancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell anti-tumor responses in vitro. J Biol Chem. 2012;287(19):15874–15885.

Bandari SK, Purushothaman A, Ramani VC, et al. Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior. Matrix Biol. 2018;65:104–118.

Mathieu M, Martin-Jaular L, Lavieu G, Théry C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 2019;21(1):9–17.

Jin H, Tang Y, Yang L, et al. Rab GTPases: central coordinators of membrane trafficking in cancer. Front Cell Dev Biol. 2021;9:648384.

Gillingham AK, Sinka R, Torres IL, Lilley KS, Munro S. Toward a comprehensive map of the effectors of Rab GTPases. Dev Cell. 2014;31(3):358–373.

Matsui T, Sakamaki Y, Nakashima S, Fukuda M. Rab39 and its effector UACA regulate basolateral exosome release from polarized epithelial cells. Cell Rep. 2022;39(9):110875.

Lamber EP, Siedenburg AC, Barr FA. Rab regulation by GEFs and GAPs during membrane traffic. Curr Opin Cell Biol. 2019;59:34–39.

Homma Y, Hiragi S, Fukuda M. Rab family of small GTPases: an updated view on their regulation and functions. FEBS J. 2021;288(1):36–55.

Ye Z, Xiong Y, Peng W, et al. Manipulation of PD-L1 endosomal trafficking promotes anti-cancer immunity. Adv Sci. 2023;10(6):e2206411.

Schuhmacher JS, Tom Dieck S, Christoforidis S, et al. The Rab5 effector FERRY links early endosomes with mRNA localization. Mol Cell. 2023;83(11):1839–1855.e13.

Yasuda S, Morishita S, Fujita A, et al. Mon1-Ccz1 activates Rab7 only on late endosomes and dissociates from the lysosome in mammalian cells. J Cell Sci. 2016;129(2):329–340.

Messenger SW, Woo SS, Sun Z, Martin TFJ. Correction: a Ca²⁺-stimulated exosome release pathway in cancer cells is regulated by Munc13-4. J Cell Biol. 2019;218(4):1423.

Ostrowski M, Carmo NB, Krumeich S, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010;12(1):19 13.

Camelo C, Körte A, Jacobs T, Luschnig S. Tracheal tube fusion in Drosophila involves release of extracellular vesicles from multivesicular bodies. J Cell Sci. 2022;135(3):jcs259590.

Gorji-Bahri G, Moghimi HR, Hashemi A. RAB5A is associated with genes involved in exosome secretion: integration of bioinformatics analysis and experimental validation. J Cell Biochem. 2021;122(3–4):425–441.

Li W, Hu Y, Jiang T, et al. Rab27A regulates exosome secretion from lung adenocarcinoma cells A549: involvement of EPI64. APMIS. 2014;122(11):1080–1087.

Cheng WC, Liao TT, Lin CC, et al. RAB27B-activated secretion of stem-like tumor exosomes delivers the biomarker microRNA-146a-5p, which promotes tumorigenesis and associates with an immunosuppressive tumor microenvironment in colorectal cancer. Int J Cancer. 2019;145(8):2209–2224.

Bai S, Hou W, Yao Y, et al. Exocyst controls exosome biogenesis via Rab11a. Mol Ther Nucleic Acids. 2021;27:535–546.

Sun L, He M, Xu N, et al. Regulation of RAB22A by mir-193b inhibits breast cancer growth and metastasis mediated by exosomes. Int J Oncol. 2018;53(6):2705–2714.

Zhang T, Zhao L, Han L, et al. TRX2/Rab35 interaction impairs exosome secretion by inducing Rab35 degradation. Int J Mol Sci. 2022;23(12):6557.

Wu S, Tang C, Zhang QW, et al. Overexpression of RAB31 in gastric cancer is associated with released exosomes and increased tumor cell invasion and metastasis. Cancer Med. 2023;12(12):13497–13510.

Skotland T, Hessvik NP, Sandvig K, Llorente A. Exosomal lipid composition and the role of ether lipids and phosphoinositides in exosome biology. J Lipid Res. 2019;60(1):9–18.

Zhang J, Tan J, Wang M, et al. Lipid-induced DRAM recruits STOM to lysosomes and induces LMP to promote exosome release from hepatocytes in NAFLD. Sci Adv. 2021;7(45):eabh1541.

Baek AE, Krawczynska N, Das Gupta A, et al. The cholesterol metabolite 27HC increases secretion of extracellular vesicles which promote breast cancer progression. Endocrinology. 2021;162(7):bqab095.

Zhao Z, Zhong L, Li P, et al. Cholesterol impairs hepatocyte lysosomal function causing M1 polarization of macrophages via exosomal miR-122-5p. Exp Cell Res. 2020;387(1):111738.

Nakamura Y, Kita S, Tanaka Y, et al. Adiponectin stimulates exosome release to enhance mesenchymal stem-cell-driven therapy of heart failure in mice. Mol Ther. 2020;28(10):2203–2219.

Kita S, Shimomura I. Stimulation of exosome biogenesis by adiponectin, a circulating factor secreted from adipocytes. J Biochem. 2021;169(2):173–179.

Andò S, Naimo GD, Gelsomino L, Catalano S, Mauro L. Novel insights into adiponectin action in breast cancer: evidence of its mechanistic effects mediated by ERα expression. Obes Rev. 2020;21(5):e13004.

Zhao W, Qin P, Zhang D, et al. Correction for: long non-coding RNA PVT1 encapsulated in bone marrow mesenchymal stem cell-derived exosomes promotes osteosarcoma growth and metastasis by stabilizing ERG and sponging miR-183-5p. Aging. 2022;14(6):2920–2922.

Sun C, Wang P, Dong W, Liu H, Sun J, Zhao L. LncRNA PVT1 promotes exosome secretion through YKT6, RAB7, and VAMP3 in pancreatic cancer. Aging (Albany NY). 2020;12(11):10427–10440.

Zhang S, Mang Y, Li L, et al. Long noncoding RNA NEAT1 changes exosome secretion and microRNA expression carried by exosomes in hepatocellular carcinoma cells. J Gastrointest Oncol. 2021;12(6):3033–3049.

Zhang Z, Zhou Y, Jia Y, Wang C, Zhang M, Xu Z. PRR34-AS1 promotes exosome secretion of VEGF and TGF-β via recruiting DDX3X to stabilize Rab27a mRNA in hepatocellular carcinoma. J Transl Med. 2022;20(1):491.

Peng X, Li X, Yang S, et al. LINC00511 drives invasive behavior in hepatocellular carcinoma by regulating exosome secretion and invadopodia formation. J Exp Clin Cancer Res. 2021;40(1):183.

Cao SQ, Zheng H, Sun BC, et al. Long non-coding RNA highly up-regulated in liver cancer promotes exosome secretion. World J Gastroenterol. 2019;25(35):5283–5299.

Wang Y, Li Y, Zhou H, Qian X, Hu Y. Syntaxin 2 promotes colorectal cancer growth by increasing the secretion of exosomes. J Cancer. 2021;12(7):2050–2058.

Yu X, Harris SL, Levine AJ. The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res. 2006;66(9):4795–4801.

Su YY, Chao CH, Hsu HY, et al. DDX3 suppresses hepatocellular carcinoma progression through modulating the secretion and composition of exosome. Am J Cancer Res. 2023;13(5):1744–1765.

Bala S, Babuta M, Catalano D, Saiju A, Szabo G. Alcohol promotes exosome biogenesis and release via modulating Rabs and miR-192 expression in human hepatocytes. Front Cell Dev Biol. 2022;9:787356.

Song JW, Zhu J, Wu XX, et al. GOLPH3/CKAP4 promotes metastasis and tumorigenicity by enhancing the secretion of exosomal WNT3A in non-small-cell lung cancer. Cell Death Dis. 2021;12(11):976.

Yan C, Tian X, Li J, et al. Erratum. A high-fat diet attenuates AMPK α1 in adipocytes to induce exosome shedding and nonalcoholic fatty liver development in vivo. diabetes 2021;70:577–588. Diabetes. 2021;70(9):2160.

Estébanez B, Jiménez-Pavón D, Huang CJ, Cuevas MJ, González-Gallego J. Effects of exercise on exosome release and cargo in in vivo and ex vivo models: a systematic review. J Cell Physiol. 2021;236(5):3336–3353.